Abstract
One of the mechanisms of action of a new oncolytic agent, benzamide riboside (BR) is by inhibiting inosine 5′-monophosphate dehydrogenase (IMPDH) which catalyzes the formation of xanthine 5′-monophosphate from inosine 5′-monophosphate and nicotinamide adenine dinucleotide, thereby restricting the biosynthesis of guanylates. In the present study BR (10–20 μM) induced apoptosis in a human ovarian carcinoma N.1 cell line (a monoclonal derivative of its heterogenous parent line HOC-7). This was ascertained by DNA fragmentation, TUNEL assay, [poly(ADP)ribose polymerase]-cleavage and alteration in cell morphology. Apoptosis was accompanied by sustained c-Myc expression, concurrent down-regulation of cdc25A mRNA and protein, and by inhibition of Cdk2 activity. Both Cdk2 and cdc25A are G1 phase specific genes and Cdk2 is the target of Cdc25A. These studies demonstrate that BR exhibits dual mechanisms of action, first by inhibiting IMPDH, and second by inducing apoptosis, which is associated with repression of components of the cell cycle that are downstream of constitutive c-Myc expression.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by L. Fesus
Rights and permissions
About this article
Cite this article
Grusch, M., Rosenberger, G., Fuhrmann, G. et al. Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells. Cell Death Differ 6, 736–744 (1999). https://doi.org/10.1038/sj.cdd.4400546
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400546
Keywords
This article is cited by
-
Targeting purine metabolism in ovarian cancer
Journal of Ovarian Research (2022)
-
Tumor Response and Apoptosis of N1-S1 Rodent Hepatomas in Response to Intra-arterial and Intravenous Benzamide Riboside
CardioVascular and Interventional Radiology (2012)
-
Apoptotic signaling induced by benzamide riboside: an in vitro study
Molecular and Cellular Biochemistry (2009)
-
Subcellular localisation of Cdc25A determines cell fate
Cell Death & Differentiation (2004)
-
Transferrin ensures survival of ovarian carcinoma cells when apoptosis is induced by TNFα, FasL, TRAIL, or Myc
Oncogene (2003)